Поиск

Long-term results of adjuvant therapy with dabrafenib and trametinib in stage III melanoma. COMBI-AD study. This study presents the final analysis of a phase III trial that evaluated the use of 12 months of adjuvant dabrafenib plus trametinib. in patients ...

The clinic was presented by Anastasia Vladimirovna Varvyanskaya, otolaryngologist K+31 West. She moderated and spoke at a meeting on olfactory dysfunction, and also co-authored the first practical recommendations in Russia for doctors on the diagnosis and ...

The clinic was presented by Anastasia Vladimirovna Varvyanskaya, otolaryngologist K+31 West. She moderated and spoke at a meeting on olfactory dysfunction, and also co-authored the first practical recommendations in Russia for doctors on the diagnosis and ...

Your browser does not support the video tag. We are glad to share amazing news! In our clinic K+31 on Lobachevsky in the Department of Cardiology and X-ray endovascular methods of diagnosis and treatment under the guidance of the head The department of ...

Your browser does not support the video tag. We are glad to share amazing news! In our clinic K+31 on Lobachevsky in the Department of Cardiology and X-ray endovascular methods of diagnosis and treatment under the guidance of the head The department of ...

Neoadjuvant nivolumab and ipilimumab for resectable stage III melanoma Previous phase 1-2 studies in patients with resectable stage III melanoma have shown that neoadjuvant immunotherapy is more effective than adjuvant immunotherapy. In this phase 3 NADINA ...

Neoadjuvant nivolumab and ipilimumab for resectable stage III melanoma Previous phase 1-2 studies in patients with resectable stage III melanoma have shown that neoadjuvant immunotherapy is more effective than adjuvant immunotherapy. In this phase 3 NADINA ...